Diethyl Ether Gel for Prolonged Cooling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing topical cooling methods for musculoskeletal pain, such as ice sprays and gels, face challenges including irreversible tissue damage from inaccurate dosing and short-lasting pain relief due to rapid evaporation, and environmental concerns from hydrofluoralkane propellants.

Innovation Solution

A gel or microemulsion formulation comprising water, diethyl ether, and ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymer, which uses diethyl ether for rapid cooling and dimethyl ether as a propellant to maintain matrix structure and extend cooling duration, minimizing tissue damage and environmental impact.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If ice spray is used for cold anesthesia, then immediate pain relief is achieved, but tissue damage occurs due to difficulty in exact dosing

Engineering Contradiction:
Improvetime for pain reliefVSAvoidtissue damage
Core Design Contradiction:
Loss of timeVSObject-affected harmful factors

Solution Approach 1:

The patent introduces a gel matrix as an intermediary carrier that contains the volatile solvent (diethyl ether) and active pharmaceutical ingredients. This gel matrix mediates between the cooling effect and the skin, allowing controlled release and preventing direct, uncontrolled contact that causes tissue damage. The gel acts as a buffer that moderates the interaction between the volatile components and the skin surface.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Speed

If volatile solvents are used in aerosol for rapid evaporation, then cooling effect is achieved, but the effect is short-lasting due to immediate evaporation

Engineering Contradiction:
Improveevaporation speedVSAvoidduration of cooling effect
Core Design Contradiction:
SpeedVSDuration of action of moving object

Solution Approach 1:

The patent creates a continuous cooling action by having the gel matrix continuously release the volatile solvent (diethyl ether) over time. The gel structure maintains a reservoir of the volatile component that evaporates progressively, providing sustained cooling rather than a single brief evaporation event. This continuous release mechanism extends the duration of the cooling effect while maintaining therapeutic benefit.

Inventive Principle:
Principle #20Continuity of useful action

3Reliability

If hydrofluoralkanes are used as propellant in aerosol, then stable aerosol delivery is achieved, but environmental harm occurs

Engineering Contradiction:
Improveaerosol delivery stabilityVSAvoidenvironmental harm
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the propellant parameter from hydrofluoralkanes to a hydrocarbon mixture (propane/butane/isobutane). This parameter change in the propellant composition maintains the necessary aerosol delivery stability and performance while eliminating the environmental harm associated with hydrofluoralkanes. The alternative propellant mixture achieves comparable physical performance without the harmful environmental effects.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If conventional gels are used for topical application, then pain relief is achieved, but it takes 15 to 60 minutes for active ingredients to penetrate skin

Engineering Contradiction:
Improvepain relief effectivenessVSAvoidtime for skin penetration
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent incorporates the volatile solvent (diethyl ether) into the gel matrix in advance, creating a pre-loaded system that immediately begins cooling upon application. The volatile component is already positioned to act on the skin surface, providing immediate cooling effect while the active pharmaceutical ingredients simultaneously begin their penetration process. This preliminary preparation of the gel with volatile solvent eliminates the waiting time for any cooling effect to begin.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulation provides immediate and prolonged cooling effects while reducing the risk of tissue damage and environmental harm, offering a stable and effective topical cooling solution for pain relief.

Implementation Method 1

uses diethyl ether for rapid cooling

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 2

The cooling of the tissue causes analgesia through cold anesthesia

Methodology Applied
Scientific EffectCooling: Cooling

Implementation Method 3

ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymer

Methodology Applied
Scientific EffectGel formation: Gel

Implementation Method 4

dimethyl ether as a propellant

Methodology Applied
Scientific EffectAerosol: Aerosol

Data Source

PatentEP2994166B1Aqueous gels with diethylether
Publication Date: 2017.08.02 BEIERSDORF AG

AI summary

A preparation in the form of a gel or microemulsion comprising water, diethyl ether and ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymer does not show any breakdown of the gel or emulsion structure.